| Treatment type | ||||
---|---|---|---|---|---|
Nil | Outpatient | Day program | Inpatient | ||
Stage 1 | Count | 2 | 8 | 2 | 5 |
% | 11.8 | 47.1 | 11.8 | 29.4 | |
Adj. Resid. | 0.6 | 1.5 | 0.6 | −2.0 | |
P value | 0.55 | 0.13 | 0.55 | 0.05 | |
Stage 2 | Count | 7 | 23 | 7 | 13 |
% | 14 | 46 | 14 | 26.0 | |
Adj. Resid. | 1.8 | 2.7 | 1.8 | −4.5 | |
P value | 0.07 | 0.01 | 0.07 | 0.00 | |
Stage 3 | Count | 1 | 8 | 1 | 13 |
% | 4.3 | 34.8 | 4.3 | 56.5 | |
Adj. Resid. | −0.7 | 0.4 | −0.7 | 0.4 | |
P value | 0.48 | 0.69 | 0.48 | 0.69 | |
Stage 4 | Count | 4 | 14 | 4 | 59 |
% | 4.9 | 17.3 | 4.9 | 72.8 | |
Adj. Resid. | −1.5 | −3.7 | −1.5 | 5.0 | |
P value | 0.13 | 0.00 | 0.13 | 0.00 |